[1]  Schouten JS, Fa VDO, Valkenburg HA. A 12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee[J]. Ann Rheum Dis., 1992, 51(8): 932-937.
[2]  Felson D T, Dsc Y Z, Hannan M T, et al. The incidence and natural history of knee osteoarthritis in the elderly, the framingham osteoarthritis study[J]. Arthritis Rheumatol, 1995, 38(38):1500-1505.
[3]  Srikanth V K, Fryer J L, Zhai G, et al. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis 1[J]. Osteoarthritis Cartilage, 2005, 13(9): 769-81.
[4]  Lawrence R C, Helmick C G, Arnett F C, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States[J]. Arthritis Rheum, 1998, 41(5): 778-799.
[5]  Ushiyama T, Ueyama H, Inoue K, et al. Expression of genes for estrogen receptors α and β in human articular chondrocytes [J]. Osteoarthritis Cartilage, 1999, 7(6): 560-566.
[6]  Arden N, Nevitt M C. Osteoarthritis: Epidemiology[J]. Best Pract Res Clin Rheumatol, 2006, 20(1):3 -25.
[7]  Sondergaard BC, Oestergaard S, Christiansen C, et al. The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model[J]. Arthritis Rheum, 2007, 56(8): 2674-2678.
[8]  Seeman E, Delmas PD. Bone quality--the material and structural basis of bone strength and fragility.[J]. New Engl J Med, 2006, 354(21): 2250-2261.
[9]  Schneider DL, Elizabeth BC, Morton DJ, et al. Bone mineral density and clinical hand osteoarthritis in elderly men and women: the Rancho Bernardo study.[J]. J Rheumatol, 2002, 29(7): 1467-1472.
[10]刘经甫, 田顺亮, 戴功谨. 河南南阳地区健康人群骨密度的调查[J]. 中国临床解剖学杂志, 2008, 26(1): 44-46.
[11] Parazzini F. Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy[J]. Maturitas,2003,46(3): 207-212.
[12] Cicuttini FM, Spector T, Baker J. Risk factors for osteoarthritis in the tibiofemoral and patellofemoral joints of the knee.[J]. J Rheumatol, 1997, 24(6): 1164-1167.
[13] Magliano M. Menopausal arthralgia: Fact or fiction[J]. Maturitas, 2010, 67(1): 29-33.
[14] Szoeke CE, Cicuttini FM, Guthrie JR, et al. The relationship of reports of aches and joint pains to the menopausal transition: a longitudinal study[J]. Climacteric, 2009, 11(1): 55-62.
[15] Prietoalhambra D, Javaid MK, Judge A, et al. Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study.[J]. Ann Rheum Dis, 2015, 74(3): 557-563.
[16]谢伟坚, 黄雄飞, 罗新乐, 等. 骨质疏松大鼠股骨骨折骨痂及腰椎的生物力学研究[J]. 中国临床解剖学杂志, 2003, 21(5): 507-508.
[17] Calvo E, Castañeda S, Largo R, et al. Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits[J]. Osteoarthritis Cartilage, 2007, 15(1): 69-77.
[18] Liang Y, Duan L, Xiong J. E2 regulates MMP-13 via targeting miR-140 in IL-1β-induced extracellular matrix degradation in human chondrocytes[J]. Arthritis Res Ther, 2016, 18(1):105.
[19] Sadeghi F, Esfandiari E, Hashemibeni B, et al. The effect of estrogen on the expression of cartilage-specific genes in the chondrogenesis process of adipose-derived stem cells[J]. Adv Biomed Res, 2015, 4:43.
[20] Hofbauer LC, Michael S. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases [J]. JAMA, 2004, 292(4): 490-495.
[21] Gui Y, Duan Z, Qiu X, et al. Multifarious effects of 17-β-estradiol on apolipoprotein E receptors gene expression during osteoblast differentiation in vitro[J]. Biosci Trends, 2016, 10(1):54-66.
[22]Guo YS, Sun Z, Ma J, et al. 17 β-Estradiol inhibits ER stress-induced apoptosis through promotion of TFII-I-dependent Grp78 induction in osteoblasts[J]. Lab Invest, 2014, 94(8): 906-916.
[23] Chen C, Xie J, Rajappa R, et al. Interleukin-1β and tumor necrosis factor-a increase stiffness and impair contractile function of articular chondrocytes[J]. Acta Biochim Biophys Sin ,2015, 14(2):121-129.
[24] Shi S, Wang C, Acton A J, et al. Role of sox9 in growth factor regulation of articular chondrocytes [J]. J Cell Biochem, 2015, 116(7):1391-400.
[25] Lu T, Achari Y, Sciore P, et al. Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site[J]. Biochim Biophys Acta, 2006, 1762(8):719-731.
[26]Chen J, Kamiya Y, Polur I, et al. Estrogen via estrogen receptor beta partially inhibits mandibular condylar cartilage growth[J]. Osteoarthritis Cartilage, 2014, 22(11):1861-1868.
[27] Maneix L, Servent A, Porée B, et al. Up-regulation of type II collagen gene by 17β-estradiol in articular chondrocytes involves Sp1/3, Sox-9, and estrogen receptor α[J]. J Mol Med, 2014, 92(11): 1179-1200.
[28] Christgau S, Tankó L B, Cloos P A, et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM)[J]. Menopause, 2004, 11(5): 508-518.
[29] Karsdal MA, Bay-Jensen AC, Henriksen K, et al. The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet [J]?  Menopause Int, 2012, 18(4):139-146.
[30] Kavas A, Cagatay ST, Banerjee S, et al. Potential of Raloxifene in reversing osteoarthritis-like alterations in rat chondrocytes: An in vitro, model study[J]. J Biosci, 2013, 38(1):135-147.